If this is your first visit, be sure to check out the FAQ in HCMA Announcements. You may have to register before you can post: click the register link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. Your Participation in this message board is strictly voluntary. Information and comments on the message board do not necessarily reflect the feelings, opinions, or positions of the Hypertrophic Cardiomyopathy Association. At no time should participants to this board substitute information within for individual medical advice. The Hypertrophic Cardiomyopathy Association shall not be liable for any information provided herein. All participants in this board should conduct themselves in a professional and respectful manner. Failure to do so will result in suspension or termination. The moderators of the message board working with the HCMA will be responsible for notifying participants if they have violated the rules of conduct for the board. Moderators or HCMA staff may edit any post to ensure it conforms with the rules of the board or may delete it. This community is welcoming to all those with HCM we ask that you remember each user comes to the board with information and a point of view that may differ from that which you hold, respect is critical, please post respectfully. Thank you

Announcement

Collapse
No announcement yet.

Genetic research - Sept. 2004

Collapse

About the Author

Collapse

Lisa Salberg Find out more about Lisa Salberg
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Genetic research - Sept. 2004

    Genetics & Environmental Business Week

    September 30, 2004


    HEADLINE: STATENS SERUM INSTITUTE, COPENHAGEN;
    Mutations influencing mRNA could play a role in hypertrophic cardiomyopathy

    BODY:

    Genetic and phenotypic characterization of mutations in myosin-binding
    protein C (MYBPC3) have been studied in 81 families with familial hypertrophic
    cardiomyopathy.

    Scientists in Denmark report, "Mutations in the MYBPC3 gene, encoding the
    sarcomere protein myosin-binding protein C, are among the most frequent causes
    of autosomal dominant familial hypertrophic cardiomyopathy (FHC). We studied the
    frequency, type, and pathogenetic mechanism of MYBPC3 mutations in an unselected
    cohort of 81 FHC families, consecutively enrolled at a tertiary referral center.
    "

    P.S. Andersen and colleagues of the Statens Serum Institute in Copenhagen
    reported, "Nine mutations, six of which were novel, were found in 10 (12.3%) of
    the families using single-strand conformation polymorphism and DNA sequencing. A
    frameshift mutation in exon 2 clearly suggests that haploinsufficiency is a
    pathogenetic mechanism in FHC. In addition, splice site mutations in exon 6 and
    intron 31, a deletion in exon 13, and a nonsense mutation in exon 25, all lead
    to premature termination codons, most likely causing loss of function and
    haploinsufficiency."

    "Furthermore, there were two missense mutations (D228N and A833 T) and one
    in-frame deletion (DeltaLys813). A considerable intrafamilial variation in
    phenotypic expression of MYBPC3-based FHC was noted, and we suggest that
    mutations influencing stability of mRNA could play a role in the variable
    penetrance and expressivity of the disease, perhaps via partial
    haploinsuffciency," they added.

    Andersen and colleagues published their study in the European Journal of
    Human Genetics (Genetic and phenotypic characterization of mutations in
    myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic
    cardiomyopathy: total or partial haploinsufficiency. Eur J Hum Genet,
    2004;12(8):673-677).
    Knowledge is power ... Stay informed!
    YOU can make a difference - all you have to do is try!

    Dx age 12 current age 46 and counting!
    lost: 5 family members to HCM (SCD, Stroke, CHF)
    Others diagnosed living with HCM (or gene +) include - daughter, niece, nephew, cousin, sister and many many friends!
    Therapy - ICD (implanted 97, 01, 04 and 11, medication
    Currently not obstructed
    Complications - unnecessary pacemaker and stroke (unrelated to each other)

Today's Birthdays

Collapse

Working...
X